Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 17/20 | 1.00 |
| ▸ | ABL1 | P00519 | 13/20 | 1.00 |
| ▸ | ABL2 | P42684 | 13/20 | 1.00 |
| ▸ | EGFR | P00533 | 3/20 | 0.58 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.58 |
| ▸ | FLT1 | P17948 | 1/20 | 0.58 |
| ▸ | FLT4 | P35916 | 1/20 | 0.58 |
| ▸ | KDR | P35968 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1657893 | 1.00 | SRC (1.00) | SRCABL1ABL2EGFRFGFR1 | |
| SCHEMBL3152705 | 0.96 | SRC (0.92) | SRCABL1ABL2EGFRFGFR1 | |
| SCHEMBL28565311 | 0.93 | SRC (0.88) | SRCABL1ABL2EGFRKDR | |
| SCHEMBL6187802 | 0.92 | SRC (0.85) | SRCABL1ABL2EGFRFYN | |
| SCHEMBL1659719 | 0.90 | SRC (1.00) | SRCABL1ABL2 | |
| SCHEMBL30452732 | 0.90 | SRC (1.00) | SRCABL1ABL2 | |
| SCHEMBL1657913 | 0.88 | SRC (1.00) | SRCABL1ABL2KDR | |
| SCHEMBL30453979 | 0.88 | SRC (1.00) | SRCABL1ABL2KDR | |
| SCHEMBL1657788 | 0.86 | SRC (1.00) | SRCABL1ABL2FYN | |
| SCHEMBL30453073 | 0.86 | SRC (1.00) | SRCABL1ABL2FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181362-B | Medicament for preventing and/or treating amyotrophic lateral sclerosis | 国立大学法人京都大学 | 2023-06-13 | — | — | CN | disclosed |